Loading…

Prospective evaluation of prognostic factors in operable breast cancer

In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath...

Full description

Saved in:
Bibliographic Details
Published in:British journal of cancer 1996-11, Vol.74 (9), p.1469-1478
Main Authors: HAWKINS, R. A, TESDALE, A. L, KILLEN, M. E, JACK, W. J. L, CHETTY, U, DIXON, J. M, HULME, M. J, PRESCOTT, R. J, MCINTYRE, M. A, MILLER, W. R
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953
cites
container_end_page 1478
container_issue 9
container_start_page 1469
container_title British journal of cancer
container_volume 74
creator HAWKINS, R. A
TESDALE, A. L
KILLEN, M. E
JACK, W. J. L
CHETTY, U
DIXON, J. M
HULME, M. J
PRESCOTT, R. J
MCINTYRE, M. A
MILLER, W. R
description In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath D), epidermal growth factor receptor (EGFR) activity and cyclic AMP-binding proteins (c-AMP-b). There were significant inter-relationships between ER and EGFR (r = -0.26), c-AMP-b and cath D (r = +0.32) and ER and c-AMP-b (r = +0.14). After follow-up (median 36.2 months), a total of 55 recurrences (18 locoregional only) and 35 deaths were recorded. By univariate analysis, up to 10 of 18 biochemical, clinical and histopathological variables of potential prognostic value were significantly related to disease-free interval or death, but by multivariate analysis only oestrogen receptor concentration and node status contributed significantly to risk of both distant recurrence/death; in addition, tumour size made a small contribution to the risk for a distant recurrence only. Only two parameters, tumour grade and ER concentration, were significantly related to risk of locoregional recurrence by univariate analysis, but by multivariate analysis, only tumour grade was important. It is concluded that tumour ER concentration, axillary nodal status and tumour grade remain as the most important prognostic factors in the early years after presentation of operable breast cancer, with a minor influence of tumour size. At this time, the prognostic significance of quantitative measurements of ER concentration, carefully controlled for the quality of both assay and tumour specimen, is probably greater than is generally appreciated. We have yet to identify other factors, which add significantly to the short-term prognostic value of these key features.
doi_str_mv 10.1038/bjc.1996.567
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2074769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78526770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953</originalsourceid><addsrcrecordid>eNpVkM9rFDEYhkNR2rXtrdfCHMSTs2aSya-LUIpVoaAHPYcv2W_alNnJNMks-N-bZZdFT-HjfXjf8BBy09F1R7n-5F78ujNGroVUZ2TVCc7aTjP1hqwopaqlhtEL8i7nl3oaqtU5OdemY6JXK_LwM8U8oy9hhw3uYFyghDg1cWjmFJ-mmEvwzQC-xJSbUIMZE7gRG5cQcmk8TB7TFXk7wJjx-vhekt8PX37df2sff3z9fn_32Pqei9JuOGjJ1YYiAveOguYSae-l5Ay91qCM6rQSKJ1xBt3APWdDj3zojVNG8Evy-dA7L26LG49TSTDaOYUtpD82QrD_J1N4tk9xZxlVvZKmFnw4FqT4umAudhuyx3GECeOSrdKCSaVoBT8eQF8F5YTDaaSjdu_dVu92791W7xW__fdjJ_gouubvjzlkD-OQqraQTxhnQkjBK9YcsAnKkvCU16391H7pL32ImAc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78526770</pqid></control><display><type>article</type><title>Prospective evaluation of prognostic factors in operable breast cancer</title><source>PubMed Central</source><creator>HAWKINS, R. A ; TESDALE, A. L ; KILLEN, M. E ; JACK, W. J. L ; CHETTY, U ; DIXON, J. M ; HULME, M. J ; PRESCOTT, R. J ; MCINTYRE, M. A ; MILLER, W. R</creator><creatorcontrib>HAWKINS, R. A ; TESDALE, A. L ; KILLEN, M. E ; JACK, W. J. L ; CHETTY, U ; DIXON, J. M ; HULME, M. J ; PRESCOTT, R. J ; MCINTYRE, M. A ; MILLER, W. R</creatorcontrib><description>In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath D), epidermal growth factor receptor (EGFR) activity and cyclic AMP-binding proteins (c-AMP-b). There were significant inter-relationships between ER and EGFR (r = -0.26), c-AMP-b and cath D (r = +0.32) and ER and c-AMP-b (r = +0.14). After follow-up (median 36.2 months), a total of 55 recurrences (18 locoregional only) and 35 deaths were recorded. By univariate analysis, up to 10 of 18 biochemical, clinical and histopathological variables of potential prognostic value were significantly related to disease-free interval or death, but by multivariate analysis only oestrogen receptor concentration and node status contributed significantly to risk of both distant recurrence/death; in addition, tumour size made a small contribution to the risk for a distant recurrence only. Only two parameters, tumour grade and ER concentration, were significantly related to risk of locoregional recurrence by univariate analysis, but by multivariate analysis, only tumour grade was important. It is concluded that tumour ER concentration, axillary nodal status and tumour grade remain as the most important prognostic factors in the early years after presentation of operable breast cancer, with a minor influence of tumour size. At this time, the prognostic significance of quantitative measurements of ER concentration, carefully controlled for the quality of both assay and tumour specimen, is probably greater than is generally appreciated. We have yet to identify other factors, which add significantly to the short-term prognostic value of these key features.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.1996.567</identifier><identifier>PMID: 8912547</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Age Factors ; Analysis of Variance ; Biological and medical sciences ; Biomarkers, Tumor - analysis ; Breast Neoplasms - chemistry ; Breast Neoplasms - pathology ; Breast Neoplasms - surgery ; Carrier Proteins ; Cathepsin D - analysis ; Cyclic AMP Receptor Protein - analysis ; ErbB Receptors - analysis ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Mammary gland diseases ; Medical sciences ; Middle Aged ; Neoplasm Recurrence, Local ; Prognosis ; Proportional Hazards Models ; Prospective Studies ; Receptors, Estrogen - analysis ; Survival Analysis ; Tumors</subject><ispartof>British journal of cancer, 1996-11, Vol.74 (9), p.1469-1478</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074769/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074769/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3255653$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8912547$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HAWKINS, R. A</creatorcontrib><creatorcontrib>TESDALE, A. L</creatorcontrib><creatorcontrib>KILLEN, M. E</creatorcontrib><creatorcontrib>JACK, W. J. L</creatorcontrib><creatorcontrib>CHETTY, U</creatorcontrib><creatorcontrib>DIXON, J. M</creatorcontrib><creatorcontrib>HULME, M. J</creatorcontrib><creatorcontrib>PRESCOTT, R. J</creatorcontrib><creatorcontrib>MCINTYRE, M. A</creatorcontrib><creatorcontrib>MILLER, W. R</creatorcontrib><title>Prospective evaluation of prognostic factors in operable breast cancer</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><description>In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath D), epidermal growth factor receptor (EGFR) activity and cyclic AMP-binding proteins (c-AMP-b). There were significant inter-relationships between ER and EGFR (r = -0.26), c-AMP-b and cath D (r = +0.32) and ER and c-AMP-b (r = +0.14). After follow-up (median 36.2 months), a total of 55 recurrences (18 locoregional only) and 35 deaths were recorded. By univariate analysis, up to 10 of 18 biochemical, clinical and histopathological variables of potential prognostic value were significantly related to disease-free interval or death, but by multivariate analysis only oestrogen receptor concentration and node status contributed significantly to risk of both distant recurrence/death; in addition, tumour size made a small contribution to the risk for a distant recurrence only. Only two parameters, tumour grade and ER concentration, were significantly related to risk of locoregional recurrence by univariate analysis, but by multivariate analysis, only tumour grade was important. It is concluded that tumour ER concentration, axillary nodal status and tumour grade remain as the most important prognostic factors in the early years after presentation of operable breast cancer, with a minor influence of tumour size. At this time, the prognostic significance of quantitative measurements of ER concentration, carefully controlled for the quality of both assay and tumour specimen, is probably greater than is generally appreciated. We have yet to identify other factors, which add significantly to the short-term prognostic value of these key features.</description><subject>Age Factors</subject><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Breast Neoplasms - chemistry</subject><subject>Breast Neoplasms - pathology</subject><subject>Breast Neoplasms - surgery</subject><subject>Carrier Proteins</subject><subject>Cathepsin D - analysis</subject><subject>Cyclic AMP Receptor Protein - analysis</subject><subject>ErbB Receptors - analysis</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>Receptors, Estrogen - analysis</subject><subject>Survival Analysis</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNpVkM9rFDEYhkNR2rXtrdfCHMSTs2aSya-LUIpVoaAHPYcv2W_alNnJNMks-N-bZZdFT-HjfXjf8BBy09F1R7n-5F78ujNGroVUZ2TVCc7aTjP1hqwopaqlhtEL8i7nl3oaqtU5OdemY6JXK_LwM8U8oy9hhw3uYFyghDg1cWjmFJ-mmEvwzQC-xJSbUIMZE7gRG5cQcmk8TB7TFXk7wJjx-vhekt8PX37df2sff3z9fn_32Pqei9JuOGjJ1YYiAveOguYSae-l5Ay91qCM6rQSKJ1xBt3APWdDj3zojVNG8Evy-dA7L26LG49TSTDaOYUtpD82QrD_J1N4tk9xZxlVvZKmFnw4FqT4umAudhuyx3GECeOSrdKCSaVoBT8eQF8F5YTDaaSjdu_dVu92791W7xW__fdjJ_gouubvjzlkD-OQqraQTxhnQkjBK9YcsAnKkvCU16391H7pL32ImAc</recordid><startdate>19961101</startdate><enddate>19961101</enddate><creator>HAWKINS, R. A</creator><creator>TESDALE, A. L</creator><creator>KILLEN, M. E</creator><creator>JACK, W. J. L</creator><creator>CHETTY, U</creator><creator>DIXON, J. M</creator><creator>HULME, M. J</creator><creator>PRESCOTT, R. J</creator><creator>MCINTYRE, M. A</creator><creator>MILLER, W. R</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19961101</creationdate><title>Prospective evaluation of prognostic factors in operable breast cancer</title><author>HAWKINS, R. A ; TESDALE, A. L ; KILLEN, M. E ; JACK, W. J. L ; CHETTY, U ; DIXON, J. M ; HULME, M. J ; PRESCOTT, R. J ; MCINTYRE, M. A ; MILLER, W. R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Age Factors</topic><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Breast Neoplasms - chemistry</topic><topic>Breast Neoplasms - pathology</topic><topic>Breast Neoplasms - surgery</topic><topic>Carrier Proteins</topic><topic>Cathepsin D - analysis</topic><topic>Cyclic AMP Receptor Protein - analysis</topic><topic>ErbB Receptors - analysis</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>Receptors, Estrogen - analysis</topic><topic>Survival Analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HAWKINS, R. A</creatorcontrib><creatorcontrib>TESDALE, A. L</creatorcontrib><creatorcontrib>KILLEN, M. E</creatorcontrib><creatorcontrib>JACK, W. J. L</creatorcontrib><creatorcontrib>CHETTY, U</creatorcontrib><creatorcontrib>DIXON, J. M</creatorcontrib><creatorcontrib>HULME, M. J</creatorcontrib><creatorcontrib>PRESCOTT, R. J</creatorcontrib><creatorcontrib>MCINTYRE, M. A</creatorcontrib><creatorcontrib>MILLER, W. R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HAWKINS, R. A</au><au>TESDALE, A. L</au><au>KILLEN, M. E</au><au>JACK, W. J. L</au><au>CHETTY, U</au><au>DIXON, J. M</au><au>HULME, M. J</au><au>PRESCOTT, R. J</au><au>MCINTYRE, M. A</au><au>MILLER, W. R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospective evaluation of prognostic factors in operable breast cancer</atitle><jtitle>British journal of cancer</jtitle><addtitle>Br J Cancer</addtitle><date>1996-11-01</date><risdate>1996</risdate><volume>74</volume><issue>9</issue><spage>1469</spage><epage>1478</epage><pages>1469-1478</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>In 215 patients with operable breast cancer (T1-T3, N0-1, M0) and no other or previous cancer, presenting to a single breast unit, sufficient tumour was available for the prospective determination of four putative biochemical markers of prognosis: oestrogen receptor (ER) activity, cathepsin D (cath D), epidermal growth factor receptor (EGFR) activity and cyclic AMP-binding proteins (c-AMP-b). There were significant inter-relationships between ER and EGFR (r = -0.26), c-AMP-b and cath D (r = +0.32) and ER and c-AMP-b (r = +0.14). After follow-up (median 36.2 months), a total of 55 recurrences (18 locoregional only) and 35 deaths were recorded. By univariate analysis, up to 10 of 18 biochemical, clinical and histopathological variables of potential prognostic value were significantly related to disease-free interval or death, but by multivariate analysis only oestrogen receptor concentration and node status contributed significantly to risk of both distant recurrence/death; in addition, tumour size made a small contribution to the risk for a distant recurrence only. Only two parameters, tumour grade and ER concentration, were significantly related to risk of locoregional recurrence by univariate analysis, but by multivariate analysis, only tumour grade was important. It is concluded that tumour ER concentration, axillary nodal status and tumour grade remain as the most important prognostic factors in the early years after presentation of operable breast cancer, with a minor influence of tumour size. At this time, the prognostic significance of quantitative measurements of ER concentration, carefully controlled for the quality of both assay and tumour specimen, is probably greater than is generally appreciated. We have yet to identify other factors, which add significantly to the short-term prognostic value of these key features.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>8912547</pmid><doi>10.1038/bjc.1996.567</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 1996-11, Vol.74 (9), p.1469-1478
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2074769
source PubMed Central
subjects Age Factors
Analysis of Variance
Biological and medical sciences
Biomarkers, Tumor - analysis
Breast Neoplasms - chemistry
Breast Neoplasms - pathology
Breast Neoplasms - surgery
Carrier Proteins
Cathepsin D - analysis
Cyclic AMP Receptor Protein - analysis
ErbB Receptors - analysis
Female
Gynecology. Andrology. Obstetrics
Humans
Mammary gland diseases
Medical sciences
Middle Aged
Neoplasm Recurrence, Local
Prognosis
Proportional Hazards Models
Prospective Studies
Receptors, Estrogen - analysis
Survival Analysis
Tumors
title Prospective evaluation of prognostic factors in operable breast cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A26%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospective%20evaluation%20of%20prognostic%20factors%20in%20operable%20breast%20cancer&rft.jtitle=British%20journal%20of%20cancer&rft.au=HAWKINS,%20R.%20A&rft.date=1996-11-01&rft.volume=74&rft.issue=9&rft.spage=1469&rft.epage=1478&rft.pages=1469-1478&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/bjc.1996.567&rft_dat=%3Cproquest_pubme%3E78526770%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c435t-d3a8637d0eea3cb0a836e04c6632ec88a7971875e6b9b9ebf3c32f4e3f49b7953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78526770&rft_id=info:pmid/8912547&rfr_iscdi=true